How Maidstone and Tunbridge Wells NHS Trust is working with BXTAccelyon to offer 4D brachytherapy to patients, reducing the need for anesthesia.

The technology
4D Brachytherapy is a hybrid approach to LDR brachytherapy for prostate cancer.
It combines the benefits of both a two-stage and one-stage implant technique to create a new real-time and dynamic approach to seed brachytherapy.
It not only eliminates some of the disadvantages aligned with each approach, but also introduces a host of added benefits.

The benefits:
An effective and highly-targeted treatment option
A time-efficient procedure for both patients and clinicians
Reduced cost for the hospital – Maidstone Hospital has shortened the duration of the operating list by almost 30%
Side effects are significantly reduced for patients

The impact
Maidstone and Tunbridge Wells NHS Trust has identified 4D brachytherapy as one of the most-effective and time-efficient means of treating prostate cancer.